Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.

Côté-Daigneault J, Bessissow T, Nicolae MV, Nie R, Bitton A, Lakatos PL, Brassard P.

Inflamm Bowel Dis. 2018 Oct 5. doi: 10.1093/ibd/izy311. [Epub ahead of print]

PMID:
30295818
2.

The risk for opportunistic infections in inflammatory bowel disease with biologics: an update.

Borman ZA, Côté-Daigneault J, Colombel JF.

Expert Rev Gastroenterol Hepatol. 2018 Oct 2. doi: 10.1080/17474124.2018.1530983. [Epub ahead of print]

PMID:
30277409
3.

Langerhans cell histiocytosis presenting as Crohn's disease: a case report.

Therrien A, El Haffaf Z, Wartelle-Bladou C, Côté-Daigneault J, Nguyen BN.

Int J Colorectal Dis. 2018 Oct;33(10):1501-1504. doi: 10.1007/s00384-018-3066-y. Epub 2018 May 8.

PMID:
29737419
4.

Agreement Between Crohn's Disease Endoscopic Severity Scores Derived from Live, Video-recorded, and Central Readings.

Côté-Daigneault J, Peerani F, Katsanos K, Ullman T, Marion J, Legnani P, Cohen B, Colombel JF.

Inflamm Bowel Dis. 2018 Apr 23;24(5):e6-e7. doi: 10.1093/ibd/izy138. No abstract available.

PMID:
29688478
5.

Letter: the safety of herpes zoster vaccination for patients with inflammatory bowel disease being treated with anti-TNF medications.

Côté-Daigneault J, Luong ML, Colombel JF, Peerani F.

Aliment Pharmacol Ther. 2018 Feb;47(3):446-447. doi: 10.1111/apt.14435. No abstract available.

PMID:
29314127

Supplemental Content

Loading ...
Support Center